Massachusetts Institute Of Technology Adverum Biotechnologies, Inc. Transaction History

Massachusetts Institute Of Technology

2 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q4 2021 Feb 14, 2022	SELL	$1.74 - $2.4 $233,427 - $321,969	-134,154 Closed	0 $0
Q4 2020 Feb 05, 2021	BUY	$9.84 - $14.26 $1.32 Million - $1.91 Million	134,154 New	134,154 $1.45 Million

524K

Ticker ADVM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 99,333,600
Market Cap $522M
Description
Adverum Biotechnologies, Inc., a clinical-stage gene therapy company, develops gene therapy product candidates to treat ocular and rare diseases. Its lead product candidate is ADVM-022, a single intravitreal injection gene therapy candidate used for the treatment of patients with chronic retinal, including wet age-related macular degeneration an...

Get notified when there are updates to the investment portfolio of Massachusetts Institute Of Technology, based on Form 13F filings with the SEC.

Stay updated on Massachusetts Institute Of Technology with notifications on news.